UNCPM 22401 - Evaluation of a Differentiated Point-of-care Active Case Finding & Management Model for the Elimination of Mother-to-Child Transmission of HIV in Lilongwe and Mangochi, Malawi
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 2,426
- 试验地点
- 3
- 主要终点
- Proportion of infants who receive EID testing by age 6 months
研究概览
简要总结
Purpose: To conduct a hybrid effectiveness-implementation stepped-wedge trial to:
- Estimate the effect of the PAC-Man model, compared to SOC, on the proportion of infants who receive timely EID testing.
- Estimate the effect of the PAC-Man model, compared to SOC, on the proportion of pregnant and breastfeeding women living with HIV who receive guideline-adherent viral load testing.
- Compare implementation outcomes between the PAC-Man model and SOC.
Participants: The total study sample size is 2,426, including 2,304 mother-infant pair (MIP) survey participants, 48 high-risk pregnant/breastfeeding women living with HIV for in-depth interviews (from high-risk MIPs who participated in a survey); 10 PMTCT policy makers and Ministry of Health (MOH)/ President's Emergency Plan for AIDS Relief (PEPFAR) implementing partner senior managers for key informant interviews; and about 48-64 professional and lay health providers for focus group discussions and implementation actor surveys.
To rigorously evaluate the PAC-Man model, investigators will use a hybrid (type 3) effectiveness-implementation incomplete stepped-wedge trial design. The hybrid incomplete stepped-wedge design is a rigorous quasi-experimental design that allows for incremental "rollout" of the PAC-Man model and serial measurement of both health outcomes (for infants and mothers in Objectives 1 and 2, respectively), as well as implementation outcomes (Objective 3). The incomplete stepped-wedge design is more efficient than a complete design, minimizes costs, and reduces participant burden, without sacrificing statistical precision. Using this design, sequential crossover from control (i.e., the SOC) to intervention (i.e., SOC plus the PAC-Man model) takes place at each 'step' using cluster randomization until all clusters (defined as a group of "sites," or health facilities plus the surrounding communities in its catchment area) receive the intervention. The 12 sites included in our study will be divided into 4 clusters of 3 sites each.
详细描述
PAC-Man Model:
PAC-Man represents an integrated differentiated services delivery (DSD) model for mothers and infants that brings the following three evidence-based practices into the community for elimination of mother to child transmission (EMTCT): 1) pediatric active case finding using novel point-of-care (POC) early infant diagnosis (EID) technology; 2) same-day antiretroviral therapy (ART) initiation for infants newly diagnosed with HIV infection; and 3) maternal viral load (mVL) testing and back-to-care services. PAC-Man uses a mobile approach to offer EMTCT services in the community and reach "high risk" MIPs in which the mother living with HIV did not initiate ART, started ART late during pregnancy or breastfeeding, dropped off treatment following ART initiation, was unsuppressed on ART, was identified with HIV infection for the first-time during the post-partum period, and/or did not return with her infant for EID testing. Because these evidence-based practices are already recommended by the Ministry of Health and will be functioning at the site and not the individual level, delivering the PAC-Man model will be done under the auspices of routine care, applying an overarching implementation strategy of creating new mobile care teams equipped with new diagnostic technology who deploy the m-PIMA™ in community settings.
PAC-Man Implementation Approaches:
The overall implementation strategy being evaluated in this study is the creation of mobile care teams to deploy m-PIMA™ and provide EMTCT services in the community. Complementing this overarching strategy will be two sub-strategies used to enhance PAC-Man adoption: 1) task shifting of active case finding, EID and mVL testing, ART initiation, and back-to-care services to community health workers (CHWs), community nurses, and HIV diagnostic assistants; and 2) changing service sites to convenient locations in the community to overcome barriers to EID and mVL delivery. These strategies are intended to work in concert with the above evidence-based practices to integrate PAC-Man into the EMTCT program.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 16 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Enrolled in the national EMTCT program at a study site in the 12 months preceding a survey.
排除标准
- •The criteria for Enumerated MIP Field Survey is as follows:
- •Inclusion Criteria:
- •Age 16 years or older.
- •Enrolled in the national EMTCT program at a study site in the 12 months preceding a survey.
- •Exclusion Criteria:
- •Documented transferred out from a site prior to the field survey.
- •Participated previously in the field survey.
- •Decline informed consent.
- •The criteria for In-Depth Interviews is as follows:
- •Inclusion criteria:
- •Age 16 years or older.
- •Met high-risk criteria for PAC-Man model.
- •Participated in a field survey.
- •Exclusion criteria:
- •Decline informed consent.
- •The criteria for Focus Group Discussions is as follows:
- •Inclusion criteria:
- •Age 18 years or older.
- •MOH or implementing partner professional or lay health worker at a study site (such as nurses, community health workers, health surveillance assistants, and HIV diagnostic assistants)
- •Generally familiar with the PAC-Man model and/or EMTCT/ EID service delivery at their site.
- •Exclusion criteria:
- •Decline informed consent.
- •The criteria for Key Informant Interviews is as follows:
- •Inclusion criteria:
- •Age 18 years or older.
- •HIV/ EMTCT policy maker OR MOH/ PEPFAR implementing partner senior manager.
- •Generally familiar with HIV and/or EMTCT/ EID service delivery.
- •Exclusion criteria:
- •Decline informed consent.
- •The criteria for Implementation Actor Questionnaires is as follows:
- •Inclusion criteria:
- •Age 18 years or older.
- •Professional or lay health provider at a study site.
- •Generally familiar with HIV and/or EMTCT/ EID service delivery at their site.
- •Participated in a focus group discussion.
- •Exclusion criteria:
- •Decline informed consent.
结局指标
主要结局
Proportion of infants who receive EID testing by age 6 months
时间窗: Within 12 months of MIP enrollment in the national EMTCT program
Proportion of infants exposed to HIV who receive EID testing by age 6 months among the enumerated cohort of MIPs with infants at least 6 weeks old at all study sites.
次要结局
- Median age at ART initiation among infants(Within 12 months of MIP enrollment in the national EMTCT program)
- Proportion of infants who receive EID testing by age 2 months(Within 12 months of MIP enrollment in the national EMTCT program)
- Proportion of infants who receive EID testing by age 12 months(Within 12 months of MIP enrollment in the national EMTCT program)
- Proportion of infants who initiate ART(Within 12 months of MIP enrollment in the national EMTCT program)
- Proportion of infants with HIV retained in care at 6 months post-ART initiation(Within 12 months of MIP enrollment in the national EMTCT program)
- Proportion of MIPs who received enhanced adherence counseling(Within 12 months of MIP enrollment in the national EMTCT program)
- Median time to ART initiation among infants(Within 12 months of MIP enrollment in the national EMTCT program)
- Proportion of MIPs reached with viral load testing(Within 12 months of MIP enrollment in the national EMTCT program)
- Proportion of high-risk infants who receive EID testing by age 6 months(Within 12 months of MIP enrollment in the national EMTCT program)
- Proportion of infants who initiate ART the same day as diagnosis(Within 12 months of MIP enrollment in the national EMTCT program)
- Proportion of MIPs virally suppressed at 12 months(Within 12 months of MIP enrollment in the national EMTCT program)
- Proportion of MIPs who resumed ART(Within 12 months of MIP enrollment in the national EMTCT program)
- Median infant results return time(Within 12 months of MIP enrollment in the national EMTCT program)
- Proportion of infants newly diagnosed with HIV(Within 12 months of MIP enrollment in the national EMTCT program)
- Proportion of infants with HIV retained in care at 3 months post-ART initiation(Within 12 months of MIP enrollment in the national EMTCT program)
- Proportion of high-risk MIPs reached with viral load testing(Within 12 months of MIP enrollment in the national EMTCT program)
- Proportion of high-risk MIPs virally suppressed at 6 months(Within 12 months of MIP enrollment in the national EMTCT program)
- Proportion of MIPs retained in care at 12 months(Within 12 months of MIP enrollment in the national EMTCT program)
- Implementation - cost per pediatric case(6-12 months after sites switch to intervention; study endline (Approximately 12 months from the time that last study sites are switched to the intervention))
- Proportion of MIPs virally suppressed at 6 months(Within 12 months of MIP enrollment in the national EMTCT program)
- Proportion of high-risk MIPs virally suppressed at 12 months(Within 12 months of MIP enrollment in the national EMTCT program)
- Proportion of MIPs retained in care at 6 months(Within 12 months of MIP enrollment in the national EMTCT program)
- Adoption - proportion of sites that adopt the PAC-Man model(6-12 months after sites switch to intervention; study endline (Approximately 12 months from the time that last study sites are switched to the intervention))
- Adoption - proportion of providers who adopt the PAC-Man model(6-12 months after sites switch to intervention; study endline (Approximately 12 months from the time that last study sites are switched to the intervention))
- Implementation - cost per unsuppressed MIP(6-12 months after sites switch to intervention; study endline (Approximately 12 months from the time that last study sites are switched to the intervention))